Corona-V-image.jpg?strip=all&lossy=1&ssl=1

A new study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2. A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.


Goodrich Optical Logo


Contact us



Visit us anytime

Goodrich Optical, 2450 Delhi Commerce Dr. Holt, MI 48842


Send us an email

info@goodrichoptical.com



Subscribe


Sign up for our newsletter to receive all the latest eye health news as well as offers and discounts from Goodrich Optical.





    Copyright © 2019 all rights reserved.



    Copyright ©2021 all rights reserved